“…The main aims of these studies were: (i) to clarify the mode of action of second-messenger cyclic nucleotides (e.g. cAMP and cGMP), which contain a 1,3,2-dioxaphosphorinane moiety and play important roles in hormone action and cell communication [5,8]; (ii) to acquire more information on the biotransformations of the clinically widely used antitumour agent cyclophosphamide and its analogues, which contain a 1,3,2-oxazaphosphorinane ring, in order to develop compounds with improved action and to reveal certain structure-activity relationships [2,9]; (iii) to synthesise novel, potentially active 1,3,2-diheterophosphorinane derivatives [10][11][12][13]; and (iv) to investigate the unique conformational behaviour of differently substituted six-membered P-hetero rings [1][2][3][4][5][6][7]. In contrast to the 1,3,2-dioxa-and 1,3,2-oxazaphosphorinanes, the corresponding 1,3,2-diaza analogues have been less comprehensively studied, although their synthetic importance increased when 1,3,2-diazaphosphinane phosphoramides proved to be effective auxiliaries for the promotion of stereoselective carbon-carbon or carbonhydrogen bond-forming reactions [14].…”